Traders Unite!

U-Turn Trade Alert: 11/30/2017

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. It operates through three segments: Biotechnology, Protein Platforms, and Diagnostics. The company’s strengths are revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and good cash flow from operations.

Symbol: TECH
Order: Buy
Price: $135.00
Stop Loss: $132.11
Take Profit: $140.76

No comments yet.

Leave a Reply